Oesophageal Cancer Trial, Recruiting NCT05443841 Sponsor: Fudan University Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT05443841
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with esophageal cancer that has been confirmed by a tissue sample (biopsy) before starting any treatment
  • Your cancer is considered removable by surgery, and scans show it has not spread to distant parts of the body
  • Surgeons believe the cancer can be fully removed with no cancer cells left behind (a "clean margin" surgery)
  • You have no history of any other type of cancer

Who may not be able to join:

  • You have serious problems with one or more major organs that would make surgery high-risk (confirm with trial site)
  • You have already had a procedure to remove tissue from the lining of the food pipe using techniques called ESD or EMR
  • It would not be possible to rinse the chest cavity with fluid during surgery due to internal scarring or tissue sticking together (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Haiquan Chen, MD, Fudan University

Phone: 086-64175590-82500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 July 2022
Est. completion
1 July 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

number of patients who had positive pleural lavage cytology

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov